共 32 条
- [1] Cerchione C(2017)Pegfilgrastim in primary prophylaxis of febrile neutropenia following frontline bendamustine plus rituximab treatment in patients with indolent non-Hodgkin lymphoma: a single center, real-life experience Support Care Cancer 25 839-845
- [2] De Renzo A(2008)Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOP Ann Hematol 87 277-283
- [3] Di Perna M(2015)Phase II study of bendamustine combined with rituximab in relapsed/refractory mantle cell lymphoma: efficacy, tolerability, and safety findings Ann Hematol 94 2025-2032
- [4] Della Pepa R(2008)Phase II multicenter study of bendamustine plus rituximab in patients with relapsed indolent B-cell and mantle cell non-Hodgkin’s lymphoma J Clin Oncol 26 4473-4479
- [5] Pugliese N(undefined)undefined undefined undefined undefined-undefined
- [6] Catalano L(undefined)undefined undefined undefined undefined-undefined
- [7] Pane F(undefined)undefined undefined undefined undefined-undefined
- [8] Picardi M(undefined)undefined undefined undefined undefined-undefined
- [9] Bosly A(undefined)undefined undefined undefined undefined-undefined
- [10] Bron D(undefined)undefined undefined undefined undefined-undefined